308 related articles for article (PubMed ID: 14631616)
1. Use of recombinant factor VIIa for bleeding in children with Glanzmann thrombasthenia.
Cağlar K; Cetinkaya A; Aytaç S; Gümrük F; Gürgey A
Pediatr Hematol Oncol; 2003 Sep; 20(6):435-8. PubMed ID: 14631616
[TBL] [Abstract][Full Text] [Related]
2. Bleeding and surgery in children with Glanzmann thrombasthenia with and without the use of recombinant factor VII a.
Hennewig U; Laws HJ; Eisert S; Göbel U
Klin Padiatr; 2005; 217(6):365-70. PubMed ID: 16307424
[TBL] [Abstract][Full Text] [Related]
3. Successful use of recombinant factor VIIa (NovoSeven) during cardiac surgery in a pediatric patient with Glanzmann thrombasthenia.
Yilmaz BT; Alioglu B; Ozyurek E; Akay HT; Mercan S; Ozbek N
Pediatr Cardiol; 2005; 26(6):843-5. PubMed ID: 15690232
[TBL] [Abstract][Full Text] [Related]
4. The international, prospective Glanzmann Thrombasthenia Registry: treatment and outcomes in surgical intervention.
Poon MC; d'Oiron R; Zotz RB; Bindslev N; Di Minno MN; Di Minno G;
Haematologica; 2015 Aug; 100(8):1038-44. PubMed ID: 26001792
[TBL] [Abstract][Full Text] [Related]
5. Treatment of bleeding in patients with platelet disorders: is there a place for recombinant factor VIIa?
Laurian Y
Pathophysiol Haemost Thromb; 2002; 32 Suppl 1():37-40. PubMed ID: 12214146
[TBL] [Abstract][Full Text] [Related]
6. Use of rFVIIa in 4 children with Glanzmann thrombasthenia.
Valentino LA
J Pediatr Hematol Oncol; 2006 Oct; 28(10):653-8. PubMed ID: 17023825
[TBL] [Abstract][Full Text] [Related]
7. The international, prospective Glanzmann Thrombasthenia Registry: treatment modalities and outcomes of non-surgical bleeding episodes in patients with Glanzmann thrombasthenia.
Di Minno G; Zotz RB; d'Oiron R; Bindslev N; Di Minno MN; Poon MC;
Haematologica; 2015 Aug; 100(8):1031-7. PubMed ID: 26001793
[TBL] [Abstract][Full Text] [Related]
8. Successful epistaxis control in a patient with Glanzmann thrombasthenia by increased bolus injection dose of recombinant factor VIIa.
Chuansumrit A; Sangkapreecha C; Hathirat P
Thromb Haemost; 1999 Dec; 82(6):1778. PubMed ID: 10613676
[No Abstract] [Full Text] [Related]
9. Intensive menstrual bleeding successfully treated with recombinant factor VIIa in Glanzmann thrombasthenia.
Balci YI; Karabulut A; Kabukcu S; Sari I; Keskin A
Clin Appl Thromb Hemost; 2011 Aug; 17(4):320-2. PubMed ID: 20460355
[TBL] [Abstract][Full Text] [Related]
10. Successful surgery using recombinant factor VIIa for recurrent, idiopathic nonulcer duodenal bleeding in a patient with Glanzmann's thrombasthenia.
van Buuren HR; Wielenga JJ
Dig Dis Sci; 2002 Sep; 47(9):2134-6. PubMed ID: 12353868
[TBL] [Abstract][Full Text] [Related]
11. A patient with Glanzmann thrombasthenia and epistaxis successfully treated with recombinant factor VIIa.
Tengborn L; Petruson B
Thromb Haemost; 1996 Jun; 75(6):981-2. PubMed ID: 8822604
[No Abstract] [Full Text] [Related]
12. NovoSeven (recombinant factor VIIa) for the treatment of bleeding episodes and perioperative management in patients with Glanzmann's thrombasthenia.
Franchini M; Lippi G
Expert Rev Hematol; 2014 Dec; 7(6):733-40. PubMed ID: 25387838
[TBL] [Abstract][Full Text] [Related]
13. Recombinant factor VIIa is effective for bleeding and surgery in patients with Glanzmann thrombasthenia.
Poon MC; Demers C; Jobin F; Wu JW
Blood; 1999 Dec; 94(11):3951-3. PubMed ID: 10572113
[TBL] [Abstract][Full Text] [Related]
14. The use of recombinant factor VIIa in children with inherited platelet function disorders.
Almeida AM; Khair K; Hann I; Liesner R
Br J Haematol; 2003 May; 121(3):477-81. PubMed ID: 12716372
[TBL] [Abstract][Full Text] [Related]
15. Recombinant activated factor VII combined with local measures in preventing bleeding from invasive dental procedures in patients with Glanzmann thrombasthenia.
Chuansumrit A; Suwannuraks M; Sri-Udomporn N; Pongtanakul B; Worapongpaiboon S
Blood Coagul Fibrinolysis; 2003 Feb; 14(2):187-90. PubMed ID: 12632030
[TBL] [Abstract][Full Text] [Related]
16. Weekly low-dose recombinant factor VIIa prophylaxis in Glanzmann thrombasthenia.
Andiç N; Oğuz N; Gündüz E; Kiraz Bulduk T; Üsküdar Teke H
Blood Coagul Fibrinolysis; 2021 Jul; 32(5):349-351. PubMed ID: 33878047
[TBL] [Abstract][Full Text] [Related]
17. [Use of recombinant factor VII in Glanzmann thrombasthenia: a case report].
Chabchoub Ben Abdallah R; Trabelsi L; Ben Ameur S; Kammoun F; Boukédi A; Ben Salah M; Ben Hlima N; Mahfoudh A
Arch Pediatr; 2010 Jul; 17(7):1062-4. PubMed ID: 20570498
[TBL] [Abstract][Full Text] [Related]
18. Glanzmann thrombasthenia successfully operated for nasal deformation with recombinant factor VIIA.
Bay A; Oner AF
Indian Pediatr; 2006 Dec; 43(12):1094. PubMed ID: 17202611
[No Abstract] [Full Text] [Related]
19. Use of recombinant factor VIIa (NovoSeven) in patients with Glanzmann thrombasthenia.
Poon MC; d'Oiron R; Hann I; Négrier C; de Lumley L; Thomas A; Karafoulidou A; Demers C; Street A; Huth-Kühne A; Petrini P; Fressinaud E; Morfini M; Tengborn L; Marquès-Verdier A; Musso R; Devecioglu O; Houston DS; Lethagen S; Van Geet C; von Depka M; Berger C; Beurrier P; Britton HA; Gerrits W; Guthner C; Kuhle S; Lorenzo JJ; Makris PE; Nohe N; Paugy P; Pautard B; Torchet MF; Trillot N; Vicariot M; Wilde J; Winter M; Chambost H; Ingerslev J; Peters M; Strauss G
Semin Hematol; 2001 Oct; 38(4 Suppl 12):21-5. PubMed ID: 11735106
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's thrombasthenia: results of an international survey.
Poon MC; D'Oiron R; Von Depka M; Khair K; Négrier C; Karafoulidou A; Huth-Kuehne A; Morfini M;
J Thromb Haemost; 2004 Jul; 2(7):1096-103. PubMed ID: 15219192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
